Unlocking Cardioprotective Potential of Gut Microbiome: Exploring Therapeutic Strategies

被引:0
|
作者
Qu, Jun [1 ]
Meng, Fantao [2 ]
Wang, Zhen [1 ]
Xu, Wenhao [1 ]
机构
[1] Yantai Yuhuangding Hosp, Dept Internal Med Cardiovasc, Yantai, Shandong, Peoples R China
[2] Linyi Cent Hosp, Dept Internal Med Cardiovasc, Linyi, Shandong, Peoples R China
关键词
Microbiome dysbiosis; probiotics; prebiotics; synbiotics; TMAO inhibitors; atherosclerosis; INTERNATIONAL SCIENTIFIC ASSOCIATION; TRIMETHYLAMINE-N-OXIDE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CHLAMYDIA-PNEUMONIAE; CONSENSUS STATEMENT; HEART-FAILURE; SUPPLEMENTATION; CONSUMPTION; PROBIOTICS;
D O I
10.4014/jmb.2405.05019
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The microbial community inhabiting the human gut resembles a bustling metropolis, wherein beneficial bacteria play pivotal roles in regulating our bodily functions. These microorganisms adeptly break down resilient dietary fibers to fuel our energy, synthesize essential vitamins crucial for our well-being, and maintain the delicate balance of our immune system. Recent research indicates a potential correlation between alterations in the composition and activities of these gut microbes and the development of coronary artery disease (CAD). Consequently, scientists are delving into the intriguing realm of manipulating these gut inhabitants to potentially mitigate disease risks. Various promising strategies have emerged in this endeavor. Studies have evidenced that probiotics can mitigate inflammation and enhance the endothelial health of our blood vessels. Notably, strains such as Lactobacilli and Bifidobacteria have garnered substantial attention in both laboratory settings and clinical trials. Conversely, prebiotics exhibit anti-inflammatory properties and hold potential in managing conditions like hypertension and hypercholesterolemia. Synbiotics, which synergistically combine probiotics and prebiotics, show promise in regulating glucose metabolism and abnormal lipid profiles. However, uncertainties persist regarding postbiotics, while antibiotics are deemed unsuitable due to their potential adverse effects. On the other hand, TMAO blockers, such as 3,3-dimethyl-1-butanol, demonstrate encouraging outcomes in laboratory experiments owing to their anti-inflammatory and tissue-protective properties. Moreover, fecal transplantation, despite yielding mixed results, warrants further exploration and refinement. In this comprehensive review, we delve into the intricate interplay between the gut microbiota and CAD, shedding light on the multifaceted approaches researchers are employing to leverage this understanding for therapeutic advancements.
引用
收藏
页码:2413 / 2424
页数:12
相关论文
共 50 条
  • [21] The gut microbiome as therapeutic target
    Cani, Patrice D.
    Delzenne, Nathalie M.
    PHARMACOLOGY & THERAPEUTICS, 2011, 130 (02) : 202 - 212
  • [22] Unlocking the Therapeutic Potential of Apelin
    Japp, Alan G.
    Newby, David E.
    HYPERTENSION, 2016, 68 (02) : 307 - 309
  • [23] Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies
    Furst, Alec
    Gill, Tejpal
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2024, 38 (02):
  • [24] Exploring the Gut Microbiome in Myasthenia Gravis
    Thye, Angel Yun-Kuan
    Law, Jodi Woan-Fei
    Tan, Loh Teng-Hern
    Thurairajasingam, Sivakumar
    Chan, Kok-Gan
    Letchumanan, Vengadesh
    Lee, Learn-Han
    NUTRIENTS, 2022, 14 (08)
  • [25] Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma
    Amedei, Amedeo
    HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (05) : 527 - 529
  • [26] Interconnections between the Gut Microbiome and Alzheimer's Disease: Mechanisms and Therapeutic Potential
    Sait, Ahmad M.
    Day, Philip J. R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [27] Therapeutic potential of Litsea cubeba essential oil in modulating inflammation and the gut microbiome
    Xia, Liqiong
    Li, Ran
    Tao, Ting
    Zhong, Ruimin
    Du, Haifang
    Liao, Ziling
    Sun, Zhanghua
    Xu, Changqiong
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [28] A potential gut microbiome therapeutic approach for HIV-1+drug abusers
    Bertrand, S. J.
    Moran, L. M.
    Harrod, S. B.
    Mactutus, C. F.
    Booze, R. M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 : S61 - S61
  • [29] Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential
    Hussain, Ikram
    Cher, Gabriel Liu Yuan
    Abid, Muhammad Abbas
    Abid, Muhammad Bilal
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [30] Potential Functions of the Gut Microbiome and Modulation Strategies for Improving Aquatic Animal Growth
    Zhang, Zhimin
    Yang, Qiushi
    Liu, Haokun
    Jin, Junyan
    Yang, Yunxia
    Zhu, Xiaoming
    Han, Dong
    Zhou, Zhigang
    Xie, Shouqi
    REVIEWS IN AQUACULTURE, 2025, 17 (01)